Our set-up, without being described as high-throughput, allows for the processing of large numbers of samples on a regular basis which often fits the needs of clinical research projects with a constant recruitment of participants and collection of samples. It is this "intermediate" capability that has made our team and our facility suitable in the context of several research projects, including MRC and BBSRC funded projects such as the Newcastle 85+ study, Newcastle Thousand Families and HALCyon and enabled the involvement of the facility in collaborative research with other national and international Universities (Boston, USA; Leiden, Netherlands; Keio University, Tokyo, Japan; InChianti Study, Parma University, Italy) and with industrial partners (Unilever, Procter and Gamble).
We offer a wide range of procedures with very flexible costs according to the magnitude of the study. Beyond those assays already available in our lab, we can also assist researchers with the development of reliable assays for new biomarkers and overall costings for grant applications.
|Dr Carmen Martin-Ruiz|